Hello! My name is Tom Paulson, and I am a seasoned financial leader and strategy advisor. Over the years, I have grown to become a specialist in business and financial management of high-tech, biotechnology and pharmaceutical companies. I leverage my vast skillset and formidable experience in financial strategy building and management as a bridge to connect the finance and investor relations and PR domains of my employers and client organizations. In discussion, presentation and action, I am able to utilize both high level information and detailed company financial information to present and articulate a company’s performance and strategy to potential and current investors, analysts, bankers, media, and members of Congress.I bring over 35 years of experience in finance and business in a variety of roles to the table, including job titles, such as Chief Financial Officer, Vice President of Finance, Secretary and Treasurer for a variety of private and public high-tech biopharma organizations. I have successfully built the reputation of an adaptable leader and advisor, demonstrating comparable achievements in small, privately-held start-ups as well as Fortune 100 companies and in consulting as well as corporate executive roles.I have led over $380 million of numerous private and public equity transactions, including IPOs, PIPEs and follow-ons, as well as M&A deals. My experience also includes SEC reporting, financial reporting improvements, Sarbanes-Oxley, as well as long-range planning and strategic analysis. I have stellar contacts with the U.S. and International institutional investor communities, venture capital, and private equity funds as well as stock analysts and bankers from several Wall Street financial institutions.I have a BA in Finance and Marketing from Loyola University in Chicago and an MBA from University of Chicago Booth School of Business. Let me know if you want to be a part of my LinkedIn connections network.
Listed skills include Mergers And Acquisitions, Start Ups, Venture Capital, Due Diligence, and 24 others.